ResearchMoz

Browse reports in Biotechnology

Displaying 1 to 30 (of 333 records)
China Vacuum Blood Collection Industry Report, 2014-2017
Mar 2015   |   By - Research In China
The vacuum blood collection system consisting of vacuum blood collection tubes, disposable blood collection needles, tourniquets, etc transfers human venous blood to closed containers and makes it into specimens prior to blood analysis. As a key integral part of the vacuum blood collection system, vacuum blood collection tubes get chiefly used for collection and preservation of blood...
$2200
Biotechnology Deals and Alliances of 2014
Mar 2015   |   By - Current Partnering
The Biotechnology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to...
$1495
Big Biotech Deals and Alliances of 2014
Mar 2015   |   By - Current Partnering
A review of big biotech partnering trends and comprehensive directory of deals and alliances announced during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report...
$1495
Genomics Deals and Alliances of 2014
Mar 2015   |   By - Current Partnering
The Genomics Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view...
$1495
Biomarker Deals and Alliances of 2014
Mar 2015   |   By - Current Partnering
The Biomarker Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view...
$1495
Antibody Deals and Alliances of 2014
Mar 2015   |   By - Current Partnering
The Antibody Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view...
$1495
Clinical Stage Deals and Alliances of 2014
Mar 2015   |   By - Current Partnering
The Clinical Stage Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view...
$1495
Discovery Stage Deals and Alliances of 2014
Mar 2015   |   By - Current Partnering
The Discovery Stage Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to...
$1495
Public Health Deals and Alliances of 2014
Mar 2015   |   By - Current Partnering
The Public Health Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view...
$1495
Polymerase Chain Reaction (PCR) Market (Products: Instruments, and Reagents & Consumables; End-users: Pharmaceutical and Biotech Industries, Clinical Diagnostics Laboratories, Academics and Universities; and Applications: Clinical Diagnostics, Life Sciences and Others - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Feb 2015   |   By - Transparency Market Research
Polymerase chain reaction (PCR) enables DNA sequencing and helps in determining the order of its building blocks. PCR finds applications in disease diagnosis, forensic sciences, and identification of bacteria and viruses. PCR is an excellent technique for rapid detection of microbial contamination and pathogens, including those complicated to culture. These techniques are precise...
$4795
Genentech, Inc. - Product Pipeline Analysis, 2015 Update
Feb 2015   |   By - GlobalData
Genentech, Inc. (Genentech) is one of the world's leading biotech companies. The company undertakes research, development, manufacture, and marketing of biotherapeutics. Genentech focuses on developing drugs for unmet medical needs in the areas of cancer, immunological diseases and angiogenic disorders. Some of its major products include Rituxan, Avastin, Herceptin, Tarceva, Lucentis,...
$750
Platelet Rich Plasma Market (By Types: Pure-Platelet Rich Plasma, Leukocyte-Platelet Rich Plasma and Leukocyte-Platelet Rich Fibrin; By Origin: Autologus, Allogenic and Homologus; By Applications: Orthopedic Surgery, Cosmetic Surgery, General Surgery, Neurosurgery and Other Surgeries) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2020
Jan 2015   |   By - Transparency Market Research
Platelet rich plasma (PRP) is a blood plasma product in which concentration of platelets is elevated four to eight times than normal blood platelet concentration. PRP is also called platelet rich gel, platelet enriched plasma and platelet enriched gel. PRP is an effective treatment to treat various diseases such as orthopedic diseases, sports injuries, neurological diseases and...
$4795
Global Nanocatalysts Industry 2015 Market Research Report
Jan 2015   |   By - QYResearch
For overview analysis, the report introduces Nanocatalysts basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc For international and China market analysis, the report analyzes Nanocatalysts markets in China and other countries or regions (such as US, Europe, Japan, etc) by...
$2600
Neovascular Glaucoma Global Clinical Trials Review, H1, 2015
Jan 2015   |   By - GlobalData
GlobalData's clinical trial report, “Neovascular Glaucoma Global Clinical Trials Review, H1, 2015"" provides data on the Neovascular Glaucoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neovascular Glaucoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction...
$2500
Optic Neuritis Global Clinical Trials Review, H1, 2015
Jan 2015   |   By - GlobalData
GlobalData's clinical trial report, “Optic Neuritis Global Clinical Trials Review, H1, 2015"" provides data on the Optic Neuritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Optic Neuritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe....
$2500
Global Biofuel Enzymes Industry 2014 Market Research Report
Jan 2015   |   By - 9Dimen Research
2014 Global Biofuel Enzymes Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Biofuel Enzymes industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Biofuel Enzymes basics: definitions, classifications,...
$2850
Global Biosimilar Market Trends & Opportunities: 2015 Edition
Jan 2015   |   By - Daedal Research
Scope of the Report The report titled “Global Biosimilar Market: Trends & Opportunities (2015 Edition)” analyzes the global biologics market, with exhaustive discussion on demand of Biosimilars with increase in patent expiry of innovator drugs. The key market challenges recognized by the analysts and the major trends biosimilar market are presented in the...
$800
Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Dec 2014   |   By - Current Partnering
The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals. Comprehensive directory of royalty financing deals since 2007 Royalty financing contract documents Royalty financing agreement terms Royalty financing agreement structure Top...
$1995
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Dec 2014   |   By - Current Partnering
The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the world’s biopharma companies. The report provides a detailed understand and analysis of how and why companies enter manufacturing and supply deals....
$3295
China Pharmaceutical Excipients Industry Report, 2014-2017
Nov 2014   |   By - Research In China
Pharmaceutical excipients refer to adjuvants and additives used for production of pharmaceuticals and compounding of prescriptions. In addition to active ingredients, pharmaceutical excipients are also contained in pharmaceutical preparations after reasonable safety assessment. China has launched more than 500 types of pharmaceutical excipients, far less than 1,500 types of the United...
$2300
China Recombinant Protein Drug Industry Report, 2014-2017
Nov 2014   |   By - Research In China
The Chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. During 2005-2013, sales of recombinant protein drugs available in Chinese sample hospitals grew at a CAGR of 19.1%, and it is projected that China will see its actual demand for recombinant protein drugs exceed RMB40 billion in 2014. The...
$2500
Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Nov 2014   |   By - Current Partnering
The Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies.   The report provides a detailed understand and analysis of how and why companies enter option and...
$2995
Polyacetal (POM) - Global Trends, Estimates and Forecasts, 2012-2018
Nov 2014   |   By - Axis Research Mind
Global Market Watch: The Polyacetal (POM) volume market is expected to reach 2.2 million tons by 2018 primarily supported by the application sector. Globally, Automotive and Industrial together account for approximately 51.34% of the market share are expected to support the Polyacetal (POM) industry going forward. Geographical analysis for Polyacetal (POM) shows that the highest...
$4210
Polyamide (PA) - Global Trends, Estimates and Forecasts, 2012-2018
Nov 2014   |   By - Axis Research Mind
Global Market Watch: The Polyamides volume market is expected to reach 8.7 million tons by 2018 primarily supported by the product type and application sector. Globally, Transportation and Textiles and Sporting together account for approximately 44.9% (2015) of the market share are expected to support the Polyamides industry going forward. Geographical analysis for Polyamides...
$3820
Polyamide 6 (PA6) - Global Trends, Estimates and Forecasts, 2012-2018
Nov 2014   |   By - Axis Research Mind
Global Market Watch: The Polyamide 6 volume market is expected to reach 4.6 million tons by 2018 primarily supported by the application sector. Globally, Transportation and Textiles and Sporting together account for approximately 44.51% (2015) of the market share are expected to support the Polyamide 6 industry going forward. Geographical analysis for Polyamide 6 shows that...
$4210
Polyamide 66 (PA66) - Global Trends, Estimates and Forecasts, 2012-2018
Nov 2014   |   By - Axis Research Mind
Global Market Watch: The Polyamide 66 volume market is expected to reach 3.5 million tons by 2018 primarily supported by the application sector. Globally, Transport and Household /Industrial Engineering together account for approximately 48.96% (2015) of the market share are expected to support the Polyamide 66 industry going forward. Geographical analysis for Polyamide 66 shows...
$4210
Specialty Polyamides (PA) - Global Trends, Estimates and Forecasts, 2012-2018
Nov 2014   |   By - Axis Research Mind
Global Market Watch: The Specialty Polyamides volume market is expected to reach 5801.9 hundred tons by 2018 primarily supported by the application sector. Globally, Transport and Packaging together account for approximately 38.44% (2015) of the market share are expected to support the Specialty Polyamides industry going forward. Geographical analysis for Specialty Polyamides...
$4210
Coronary Stents - Global Trends, Estimates and Forecasts, 2012-2018
Nov 2014   |   By - Axis Research Mind
Global Market Watch: Global Coronary Stents sector is projected to reach US$9.5 billion by 2016. The North America accounts for nearly 41% (2015) of the global value while Europe claims approximately 29% (2018). Asia-Pacific is the fastest growing region with a CAGR of 8.8% driving a market value of US$1.5 billion by 2015. On a global scale, projections for drug eluting...
$4450
Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018
Nov 2014   |   By - Axis Research Mind
Global Market Watch: BRICSS Coronary Stents market value is expected to reach US$1 billion by 2016, primarily supported by the product types - Drug Eluting Stents, Bare Metal Stents, Absorbable Stents and …etc. China accounts for nearly 28% of the market share and India claims more than 23%. In terms of CAGR, India is the fastest growing region while China and South...
$2500
Pharmacogenomics Partnering Terms and Agreements
Nov 2014   |   By - Current Partnering
The Pharmacogenomics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomics partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter pharmacogenomics partnering deals. The majority of deals...
$1995
 
Displaying 1 to 30 (of 333 records)

Biotechnology Market Research Reports & Industry Analysis

When the term biotechnology is spoken it means several different things. It has its use in detergents, medicinal drugs, as well as in bread and beer. It is one of the rarest cross-section technologies that not only hinge disciplines as biochemistry and biology, but also encompasses other fields such as chemistry, physics, engineering, computer science, and materials science. 

In medical parlance, Biotechnology is defined as the use of cell materials and living cells that conducts research and experimentations and produces diagnostic and pharmaceutical products in preventing and treating human diseases. Discoveries such as microbial pesticides, environmental cleanup techniques, and insect-resistant crops are introduced to the market due to medical biotechnology. A few of the most prominent discoveries in this field include growth hormone and insulin. 

Pharmaceutical Biotechnology is an expanding vital area of medical science and technology that contributes to design and delivery of new therapeutic drugs in the industry. Aspects such as the development of diagnostic agents for medical tests and gene therapy for modifying the medical symptoms of hereditary diseases are key parts of biotechnology.  

The medicinal as well as the societal implications of Pharmaceutical Biotechnology is pervasive in the modern times, with facets ranging from changes in health care practices, ethical issues of treating and identifying multifarious hereditary diseases, to the national economic development. 

The global biotechnology industry is augmented to exceed $320 billion by 2015. Among the various nations, the two most prominent developing nations such as China and India are becoming attractive in the fields of industrial and agricultural biotechnology. The biotechnology market reports section of ResearchMoz covers maximum data on the biopharmaceutical segment that’s mainly constituted of insulin, vaccines, monoclonal antibodies, branded drugs, and generic drugs. Browse through our wide collection of market reports and analysis that is intended to make your search easier and provide you with accurate information for ideal market analysis. 
Biotechnology

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData